Identification of immune-related subtypes of colorectal cancer to improve antitumor immunotherapy
Abstract Immunotherapy involving immune checkpoint inhibitors (ICIs) for enhancing immune system activation is promising for tumor management. However, the patients’ responses to ICIs are different. Here, we applied a non-negative matrix factorization algorithm to establish a robust immune molecular...
Guardado en:
Autores principales: | Xiaobo Zheng, Yong Gao, Chune Yu, Guiquan Fan, Pengwu Li, Ming Zhang, Jing Yu, Mingqing Xu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/db8de9deba9d4bffa447c849eff4416b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
EFFECT OF ANTIGEN-PRIMED DENDRITIC CELL-BASED IMMUNOTHERAPY ON ANTITUMOR CELLULAR IMMUNE RESPONSE IN PATIENTS WITH COLORECTAL CANCER
por: V. V. Kurilin, et al.
Publicado: (2021) -
T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity
por: Daniela Schmid, et al.
Publicado: (2017) -
Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma
por: Rui Xing, et al.
Publicado: (2021) -
Prognostic characterization of immune molecular subtypes in non-small cell lung cancer to immunotherapy
por: Chenlu Li, et al.
Publicado: (2021) -
Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors
por: Baharak Bahmani, et al.
Publicado: (2021)